Artificial Intelligence

Whether it’s guiding clients through merger reviews in technology sectors, advising on AI-driven pricing strategies, or supporting compliance with evolving antitrust standards, our practice addresses the complex intersection of AI and antitrust. We help clients identify potential antitrust risks associated with AI, as well as leading investigations and litigation related to antitrust violations that may arise from business practices involving AI technology. We are well-versed in the nuances of domestic and international antitrust regulations and engage in policy discussions that contribute to shaping the regulatory framework surrounding AI and competition law.

Our transactional team assists clients in structuring, negotiating, and executing transactions involving AI technologies, including M&A, joint ventures, development agreements, and strategic collaborations. As businesses increasingly incorporate AI to enhance efficiencies, we help identify and mitigate risks and help develop best practices for AI governance. We also advise venture capital firms, private equity sponsors, and strategic investors on the potential legal risks and other legal implications of investing in AI companies.

Our Intellectual Property practice addresses the challenges and opportunities of AI in protecting, commercializing, and enforcing our clients’ intellectual property assets. We defend AI developers in high stakes litigation over the right to use copyrighted content in training their AI models.  We also advise on the copyright implications of AI-generated works; secure patent protection for AI innovations; guide clients in trademarking AI-generated branding elements; and assist in drafting and negotiating licensing and collaboration agreements pertaining to the development and use of AI. Additionally, we engage in advocacy to help shape policies that balance innovation and protection.

Our Legislative & Public Policy team brings a deep understanding of the legislative landscape to navigating the intricacies of AI-related legislation and public policy initiatives in this rapidly shifting regulatory environment. We engage in advocacy to influence policymaking; represent clients before legislative bodies; facilitate strategic relationships to promote collaboration in AI policy development; and assess proposed AI policies and regulations for their impact on clients’ business operations, innovation, and competitive positioning.

From drug discovery, medical device development and deployment to patient care and regulatory compliance, AI is transforming health care life sciences, and our Life Sciences team helps clients navigate this rapidly evolving environment. We draw on our deep understanding of, and familiarity with, the FDA to advise on AI’s use in developing medical devices and drugs and its use as a diagnostic tool. Additionally, We partner with clients to strategize regulatory and reimbursement pathways to get AI-based products to patients as well as the use of AI in the marketing and post-marketing of products.

Our Privacy, Cybersecurity & Data Strategy practice provides clients with the depth of experience needed to effectively navigate the complexities of AI implementation while protecting personal and sensitive information.  We offer guidance on compliance with a wide range of privacy laws and regulations, including the requirements on handling personal data in AI systems; help implement robust data protection measures; avoiding negative consequences through privacy enforcement or litigation around using personal data in AI; provide rapid response strategies for cybersecurity incidents; and help clients establish AI governance frameworks. Our lawyers collaborate with clients to develop strategies and programs that foster innovation and use privacy infrastructure to ensure legal compliance, privacy protections, ethical use of AI, and data security.